Tissue Engineered Skin Substitutes Market Size by Segments, Share, Regulatory, Reimbursement, and Forecast to 2033
Powered by
All the vital news, analysis, and commentary curated by our industry experts.
Tissue Engineered Skin Substitutes Market Report Overview
The tissue-engineered skin substitutes market size is $2.2 billion in 2023. Factors such as the rise in the prevalence of burn injuries and other skin diseases will drive the market growth at a CAGR of more than 3% during 2023-2033.
Tissue engineering for wound care management refers to the mechanical and chemical processing of materials to manufacture products that may substitute or replace all or some components that make up normal skin. Acellular or cellular, synthetic or biological may consist of a synthetic epidermis and a collagen-based dermis to encourage the formation of new tissue. In products that have a synthetic epidermis, this may be a temporary wound covering.
Tissue Engineered Skin Substitutes Market Outlook, 2023-2033 ($ Billion)
Buy the Full Report for More Insights into the Tissue Engineered Skin Substitutes Market Forecast
The tissue engineered skin substitutes market research report identifies quantitative market trends within wound care management therapeutic areas. The report offers regional quantitative and qualitative data highlighting the sales in major markets. The model also covers in detail the effects of COVID-19 on the tissue engineered skin substitutes market for 2020 and beyond. Furthermore, the report provides tissue engineered skin substitutes market share by company that will help in identifying untapped market opportunities.
Market Size (2023) | $2.2 billion |
CAGR (2023-2033) | >3% |
Forecast Period | 2023-2033 |
Historical Period | 2015-2022 |
Key Regions | · North America
· Europe · Asia Pacific · South Central America · Middle East and Africa |
Key Segments | · Acellular Skin Substitutes
· Cellular Skin Substitutes |
Leading Companies | · AbbVie Inc
· Integra LifeSciences Holdings Corp · MiMedx Group Inc · Organogenesis Holdings Inc · Smith & Nephew Plc |
Enquire & Decide | Discover the perfect solution for your business needs. Enquire now and let us help you make an informed decision before making a purchase. |
Regional Analysis of Tissue Engineered Skin Substitutes Market
The key regions in the tissue engineered skin substitutes market are North America, Europe, the Asia-Pacific, South Central America, and the Middle East & Africa. North America dominated the market in 2023.
North America has a well-developed healthcare sector and high per capita healthcare expenditures. TESS technology is especially inclined toward the elderly population for whom easily accessible healthcare is paramount. Moreover, the increasing geriatric population and developed economies of the US and Canada further fuel market growth within the region. The North American population desires more efficient solutions for their illnesses, which is an additional factor driving market growth.
Tissue Engineered Skin Substitutes Market Analysis by Regions, 2023 (%)
Buy the Full Report for More Regional-Insights in the Tissue Engineered Skin Substitutes Market
Tissue Engineered Skin Substitutes Market Segments
The tissue engineered skin substitutes market can be segmented into acellular skin substitutes and cellular skin substitutes. Acellular skin substitutes led the tissue engineered skin substitutes market in 2023.
Acellular biomaterials can stimulate the micro-environment to heal wounds without the regulatory and scientific challenges of cellular treatment. Acellular skin substitutes can be further sub-segmented into acellular skin substitutes based on amniotic membrane and other acellular skin substitutes.
Cellular Skin Substitutes contain viable cells seeded onto the matrix material. They serve as a barrier to the environment. They reduce inflammation and scarring without excessive fibrosis. This helps support wound closure.
Tissue Engineered Skin Substitutes Market Analysis by Segments, 2023 (%)
Buy the Full Report to Know More Segments-Wise Insights in the Tissue Engineered Skin Substitutes Market
Tissue Engineered Skin Substitutes Market - Competitive Landscape
In 2023, Allergan’s tissue engineered skin substitute market share was the highest
The major players in the tissue engineered skin substitutes market are:
- AbbVie Inc
- Integra LifeSciences Holdings Corp
- MiMedx Group Inc
- Organogenesis Holdings Inc
- Smith & Nephew Plc
The key strategy that major companies are following is to invest in R&D initiatives and product launches. Also, the quick responses in rebuilding the problems faced with the usage devices is a matter of market competition. Before making a huge investment, large-scale companies take a smart step. This step involves conducting extensive market research to understand exact product needs.
Tissue Engineered Skin Substitutes Market Analysis by Companies, 2023 (%)
Buy the Full Report for More Company-Wise Insights in the Tissue Engineered Skin Substitutes Market
Tissue Engineered Skin Substitutes Market Dynamics
Drivers: The key factors positively impacting tissue engineered skin substitutes market growth are the rise in the prevalence of burn injuries and other skin diseases. Also, the growing incidences of chronic and burn wounds coupled with the rising geriatric population will support the market growth.
Barriers: Factors such as the lack of feasible reimbursement policies may affect the demand for tissue engineered skin substitutes. Furthermore, the struggle to produce complex skin substitutes that can readily be transplanted in large quantities will also negatively impact the tissue engineered skin substitutes market growth.
Future Outlook: Skin substitutes will be widely in use in the coming future owing to the growth in complex models. This, would become an alternative to its natural counterpart. Demand for a side effect-free treatment, especially for skin, is a driving force for this market.
Segments Covered in the Report
Tissue Engineered Skin Substitutes Segment Outlook (Value, $ Billion, 2015-2033)
- Acellular Skin Substitutes
- Acellular Skin Substitutes Based on Amniotic Membrane
- Other Acellular Skin Substitutes
- Cellular Skin Substitutes
- Cellular Skin Substitutes Based on Amniotic Membrane
- Other Cellular Skin Substitutes
Tissue Engineered Skin Substitutes Regional Outlook (Value, $ Billion, 2015-2033)
- North America
- Europe
- Asia Pacific
- South Central America
- Middle East and Africa
Key Inclusions
The tissue engineered skin substitutes market research report includes an insightful review of the key industry trends.
- The tissue engineered skin substitutes market report offers an annualized market revenue by segment and market outlooks from 2015-2033.
- The report also includes market-level data on units, average selling prices, and market values.
Regional, country, and global tissue engineered skin substitutes market insights:
- The tissue engineered skin substitutes market share report offers qualitative insights on global and regional trends. In addition, GlobalData analysts provide unique country-specific insights on the market.
- Tissue engineered skin substitutes market SWOT analysis.
- The report provides trends and tissue engineered skin substitutes market competitive dynamics.
Buy the Full Report for More Insights on the Tissue Engineered Skin Substitutes Market Share, Download a Free Sample Report
Learn about consumer behavior through the detailed overview of segments and the healthcare system. The report also offers information on reimbursement policies and the regulatory landscape.
- Country-specific overview of the healthcare system.
- Country-specific reimbursement policies.
- Country-specific medtech regulatory landscape.
Robust methodologies and sources enable the model to provide an extensive and accurate overview of the market. These syndicated models include demand and supply-side primary sources including Key opinion leaders. Also, determine market trends through real-world data sources including databases of government procedures and hospital purchasing.
Companies covered – Integra LifeSciences Corp, LifeNet Health Inc, MiMedx Group Inc, Organogenesis Holdings Inc, Smith & Nephew Plc, Allergan Ltd, and others.
Countries covered – United States, United Kingdom, Germany, France, Italy, Spain, Brazil, China, India, Russia, Japan, Australia, Canada, Mexico, South Korea, Denmark, Ireland, Netherlands, New Zealand, South Africa, Sweden, Switzerland, Austria, Belgium, Finland, Israel, Norway, Poland, Portugal, Taiwan, Czech Republic, Greece, Hungary, Turkey, Egypt, Saudi Arabia, United Arab Emirates, Argentina, and Chile.
Scope
- Extensive coverage of the tissue engineered skin substitutes market under development.
- An exhaustive list of major pipeline products and their details, including product description, licensing and collaboration details, and other developmental activities.
- Reviews of major players involved in the development of the tissue engineered skin substitutes market and lists all their pipeline projects.
- Coverage of pipeline products based on various stages of development ranging from early development to approved/issued stage.
- Key clinical trial data of ongoing clinical trials specific to pipeline products.
- Recent developments in the segment/industry.
Reasons to Buy
- Understand the COVID-19 impact on tissue engineered skin substitutes market.
- Design your licensing strategies through a review of products, technologies, and companies with the most robust pipeline.
- Develop business strategies by understanding the trends shaping and driving tissue engineered skin substitutes market.
- Understand the trends, innovative product launches, technologies, segments, and companies that will impact the market in the future.
- Formulate effective sales and marketing strategies with a detailed evaluation of tissue engineered skin substitutes market share by company. Identify strong competitors and create winning strategies to stand out in the global tissue engineered skin substitutes market.
- Track regional tissue engineered skin substitute market sales as well as country-specific transactions from 2015-2033.
- Organize your sales and marketing efforts by identifying the global tissue engineered skin substitutes market segments that present maximum opportunities. Such details will help to make investments and strategic partnerships.
- Organize your sales and marketing efforts by identifying the market categories and segments that present maximum opportunities for consolidations, investments, and strategic partnerships.
LifeNet Health Inc
MiMedx Group Inc
Organogenesis Holdings Inc
Smith & Nephew Plc
Allergan Ltd
Others
Frequently asked questions
-
What was the tissue engineered skin substitutes market size in 2023?
The tissue engineered skin substitutes market size was $2.2 billion in 2023.
-
What will be the growth rate of the tissue engineered skin substitutes market in the forecast period?
The tissue engineered skin substitutes market will grow at a CAGR of more than 3% during 2023-2033.
-
Which was the leading segment of the tissue engineered skin substitutes market in 2023?
Acellular skin substitutes led the tissue engineered skin substitutes market in 2023.
-
Which region held the largest share of the tissue engineered skin substitutes market in 2023?
North America held the largest tissue engineered skin substitutes market share in 2023.
-
Which are the major players operating in the tissue engineered skin substitutes market?
A few of the leading companies in the tissue engineered skin substitutes market are AbbVie Inc, Integra LifeSciences Holdings Corp, MiMedx Group Inc, Organogenesis Holdings Inc, and Smith & Nephew Plc among others.
Get in touch to find out about multi-purchase discounts
reportstore@globaldata.com
Tel +44 20 7947 2745
Every customer’s requirement is unique. With over 220,000 construction projects tracked, we can create a tailored dataset for you based on the types of projects you are looking for. Please get in touch with your specific requirements and we can send you a quote.